About David Jorden
Form D filings for Nanospectra Biosciences from 2013 to 2023 list David Jorden as chief executive officer and director.
David Jorden first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name David Jorden in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Jorden works with at each company, as listed on that company's latest Form D.
Nanospectra Biosciences Inc. · Form D, Mar 15, 2023
BS
Blair Shamel
Director
KS
Kevin Smith
Director
PP
Patrick Pace
Director
BN
Bradley Nyberg
Director
GG
Glenn Goodrich
Executive officer